TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10651673

Group type: EXPERIMENTAL
Intervention: Hypotension group (sodium nitroprusside-induced controlled hypotension, mean arterial blood pressure adjusted to 50 mmHg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypotension group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (mean arterial blood pressure > 70 mmHg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 9339606

Group type: EXPERIMENTAL
Intervention: Legionella testing (culture, DFA, IIF, ELISA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Environmental samples
Number of subjects: 100

Group type: COMPARATOR
Intervention: Controls (age and sex matched)
Number of subjects: 100
Study: 7678046

Group type: EXPERIMENTAL
Intervention: Dietary ferrous sulphate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ferrous sulphate
Number of subjects: 50
Study: 3746904

Group type: EXPERIMENTAL
Intervention: Behavioral visual acuity training program
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 20
Study: 29929894

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography combined with pressure waveform transduction
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pressure waveform transduction alone
Number of subjects: 48
Study: 27923379

Group type: EXPERIMENTAL
Intervention: Reusable pads (AFRIpads)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Existing improvised methods (predominately new or old cloth)
Number of subjects: 205
Study: 24090625

Group type: EXPERIMENTAL
Intervention: Baseline resilience
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Change in resilience (increased or decreased)
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Age, gender, educational attainment, combat exposure, PTSD symptom severity, self-reported alcohol abuse
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Psychological resilience
Number of subjects: 1090
Study: 23065392

Group type: EXPERIMENTAL
Intervention: Crude methanolic extracts of Euphorbia helioscopia at concentrations of 12.5 mg/ml, 25 mg/ml, and 50 mg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aqueous extracts of Euphorbia helioscopia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methanolic and aqueous extracts of Euphorbia helioscopia at concentrations ranging from 100 to 500 mg/ml
Number of subjects: 0
Study: 20848384

Group type: EXPERIMENTAL
Intervention: Illustration group (detailed illustrations regarding medication use)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Oral group (standard oral postoperative instructions)
Number of subjects: 65
Study: 17365753

Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 741

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 741
Study: 15478523

Group type: EXPERIMENTAL
Intervention: Tolterodine, 2 mg twice daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tolterodine at self-selected doses (SSDs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oxybutynin at self-selected doses (SSDs)
Number of subjects: 10
Study: 11895302

Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound (PD) in patients with enlarged, abnormal tendons
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MRI and conventional ultrasound (US)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 11
Study: 9627202

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lamotrigine (LTG)
Number of subjects: 0
Study: 7882730

Group type: EXPERIMENTAL
Intervention: RYHB vaccine (20 micrograms per dose)
Number of subjects: 106

Group type: COMPARATOR
Intervention: PHB vaccine (20 micrograms per dose)
Number of subjects: 106
Study: 2908752

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 100
Study: 30219195

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural block (GI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Continuous epidural block (GII)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural block (GI) and Continuous epidural block (GII)
Number of subjects: 80
Study: 30025713

Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shockwave therapy given over 2 weeks
Number of subjects: 0
Study: 26947417

Group type: EXPERIMENTAL
Intervention: Pisces group (born under the sign of Pisces)
Number of subjects: 798

Group type: COMPARATOR
Intervention: Non-Pisces group (not born under the sign of Pisces)
Number of subjects: 798
Study: 24806159

Group type: EXPERIMENTAL
Intervention: Letermovir 60 mg per day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Letermovir 120 mg per day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Letermovir 240 mg per day
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 22089962

Group type: EXPERIMENTAL
Intervention: Electrical stimulation combined with passive locomotion-like movement
Number of subjects: 27

Group type: COMPARATOR
Intervention: Electrical stimulation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Passive locomotion-like movement
Number of subjects: 27
Study: 19806284

Group type: EXPERIMENTAL
Intervention: Hip protectors that have undergone adequate biomechanical testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham hip protectors
Number of subjects: 0
Study: 17050656

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 22
Study: 16187862

Group type: EXPERIMENTAL
Intervention: Social condition (participants expected to meet the person who induced anger)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsocial condition (participants had no expectation to meet the person who induced anger)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social appraisal
Number of subjects: 0
Study: 12231566

Group type: EXPERIMENTAL
Intervention: CEE+MP or MPA
Number of subjects: 35
Study: 10604643

Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment within the first two days of illness
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment on the second day of illness
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment on and after the third day of illness
Number of subjects: 292

Group type: COMPARATOR
Intervention: No antimicrobial agents
Number of subjects: 292
Study: 7499739

Group type: EXPERIMENTAL
Intervention: Cordocentesis
Number of subjects: 21

Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 21
Study: 1743247

Group type: EXPERIMENTAL
Intervention: propoxyphene + ethanol
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo + ethanol
Number of subjects: 12

Group type: COMPARATOR
Intervention: propoxyphene alone
Number of subjects: 12
Study: 6764935

Group type: EXPERIMENTAL
Intervention: Tryptophan (3 grams daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Tryptophan and Placebo)
Number of subjects: 30
Study: 31142533

Group type: EXPERIMENTAL
Intervention: 1.5% olanexidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10% povidone-iodine
Number of subjects: 0
Study: 28660649

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 4262

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 4262
Study: 26076313

Group type: EXPERIMENTAL
Intervention: Assist (talk about quitting or recommend stop‐smoking medications or recommend counseling)
Number of subjects: 3336

Group type: EXPERIMENTAL
Intervention: Arrange follow‐up
Number of subjects: 3336

Group type: COMPARATOR
Intervention: Ask
Number of subjects: 3336

Group type: COMPARATOR
Intervention: Advise
Number of subjects: 3336

Group type: COMPARATOR
Intervention: Assess
Number of subjects: 3336

Group type: EXPERIMENTAL
Intervention: Assist
Number of subjects: 3336
Study: 23498969

Group type: EXPERIMENTAL
Intervention: Individual Lifestyle Group (ILG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Partner Lifestyle Group (PLG)
Number of subjects: 27
Study: 21454746

Group type: EXPERIMENTAL
Intervention: Skin surface cooling (∼12-15°C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normothermia (∼34°C)
Number of subjects: 8
Study: 19584748

Group type: EXPERIMENTAL
Intervention: Inhibitory repetitive transcranial magnetic stimulation applied to the contralesional motor system
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inhibitory paired associative stimulation applied to the contralesional motor system
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Facilitatory anodal transcranial direct current stimulation applied to the ipsilesional motor system
Number of subjects: 9
Study: 17295725

Group type: EXPERIMENTAL
Intervention: Alcohol (0.7 g/kg males; 0.63 g/kg females)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Drink after stress (DAS)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No stress control (NSC)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Subjective desire for alcohol under alcohol condition
Number of subjects: 180
Study: 15214221

Group type: EXPERIMENTAL
Intervention: Early loading of implants with full-arch prostheses after 9 to 18 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Delayed loading of implants with full-arch prostheses after 2.5 to 5.1 months
Number of subjects: 24
Study: 11822766

Group type: EXPERIMENTAL
Intervention: Oral vinorelbine at a dose of 80 mg/m2
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intravenous vinorelbine at a dose of 25 mg/m2
Number of subjects: 32
Study: 9805321

Group type: EXPERIMENTAL
Intervention: Forebrain commissurotomy (L.B.)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Agenesis of the corpus callosum (R.B.)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal participants
Number of subjects: 2
Study: 7702447

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Focal interpersonal therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Behavior therapy
Number of subjects: 99
Study: 2084236

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) therapy
Number of subjects: 45
Study: 32776

Group type: EXPERIMENTAL
Intervention: Lorazepam (3.2 mg twice daily)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 31925984

Group type: EXPERIMENTAL
Intervention: Definitive abutment group (DEF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healing abutment group (HEA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DEF
Number of subjects: 24

Group type: COMPARATOR
Intervention: HEA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DEF and HEA
Number of subjects: 24
Study: 31734672

Group type: EXPERIMENTAL
Intervention: Isotretinoin plus levocetirizine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isotretinoin alone
Number of subjects: 100
Study: 28396102

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg
Number of subjects: 1196

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1196
Study: 25873189

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 84
Study: 23525572

Group type: EXPERIMENTAL
Intervention: Feedback about joint position (pF-group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feedback about force (fF-group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subthreshold transcranial magnetic stimulation over the right motor cortex
Number of subjects: 0
Study: 20143449

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control (no GM-CSF)
Number of subjects: 259
Study: 18478206

Group type: EXPERIMENTAL
Intervention: Metyrapone, 1500 mg
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 16098636

Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine (104.7, 105.2 or 105.8 ffu)
Number of subjects: 2155
Study: 12932243

Group type: EXPERIMENTAL
Intervention: 1% pyrithione zinc shampoo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 5% minoxidil topical solution
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination of 1% pyrithione zinc shampoo and 5% minoxidil topical solution
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo shampoo
Number of subjects: 200
Study: 10785587

Group type: EXPERIMENTAL
Intervention: Various statistical techniques for analyzing Quality of Life (QL) data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary statistical methods for QL analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity or supportive analysis
Number of subjects: 0
Study: 8865946

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1.5 g as single shot prophylaxis before hemodilution (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1.5 g as single shot prophylaxis after hemodilution (group B)
Number of subjects: 20
Study: 1909700

Group type: EXPERIMENTAL
Intervention: Mesna (20% of ifosfamide dose, intravenously, three times daily for 5 days)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Mesna
Number of subjects: 91
Study: 6090258

Group type: EXPERIMENTAL
Intervention: Naloxone (opioid blocker)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adrenergic blockers (phentolamine and propranolol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of opioid and adrenergic blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Labyrinthine stimulation (active stressful stimulus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cold pain (active stressful stimulus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adrenergic blockade during labyrinthine stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active stressful stimuli (labyrinthine stimulation, cold pain, or both)
Number of subjects: 0
Study: 30878146

Group type: EXPERIMENTAL
Intervention: Treatment group (clinical trial participants)
Number of subjects: 79
Study: 30577809

Group type: EXPERIMENTAL
Intervention: Slide-show message
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Video message
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standard method
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All methods combined
Number of subjects: 30
Study: 26341915

Group type: EXPERIMENTAL
Intervention: 4-n-butylresorcinol DMN patch
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (DMN without 4-n-butylresorcinol)
Number of subjects: 45
Study: 24513622

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic training (IHT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 12
Study: 23061875

Group type: EXPERIMENTAL
Intervention: Walking and Behavioural intervention (WB)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Walking intervention (W)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Self-directed control (C)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: All groups (WB, W, C)
Number of subjects: 222
Study: 21252605

Group type: EXPERIMENTAL
Intervention: Scapulothoracic exercises in addition to glenohumeral ROM exercises
Number of subjects: 29

Group type: COMPARATOR
Intervention: Glenohumeral ROM exercises only
Number of subjects: 29
Study: 17624475

Group type: EXPERIMENTAL
Intervention: Low Dose Computed Tomography (LDCT)
Number of subjects: 765

Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 765
Study: 17346594

Group type: EXPERIMENTAL
Intervention: Fluoridated elastomerics
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonfluoridated elastomerics
Number of subjects: 12
Study: 15685819

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus paclitaxel
Number of subjects: 221

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 221
Study: 10865313

Group type: EXPERIMENTAL
Intervention: 50 CGE
Number of subjects: 188

Group type: COMPARATOR
Intervention: 70 CGE
Number of subjects: 188
Study: 9250827

Group type: EXPERIMENTAL
Intervention: IL‐6 administered at 1 micro/kg/day for 3 patients
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IL‐6 administered at 2.5 microg/kg/day for 3 patients
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IL‐6
Number of subjects: 6

Group type: COMPARATOR
Intervention: GM‐CSF (historical control)
Number of subjects: 6
Study: 8472520

Group type: EXPERIMENTAL
Intervention: ST‐679 (1200 mg, single oral dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paracetamol (1000 mg, single oral dose)
Number of subjects: 40
Study: 2951799

Group type: EXPERIMENTAL
Intervention: Duovent (fenoterol-ipratropium bromide)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30421268

Group type: EXPERIMENTAL
Intervention: Religion-spiritual program (6 sessions, 30-45 min each)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 93
Study: 27746239

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation during pregnancy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: C-section birth
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Cord blood vitamin D levels
Number of subjects: 333
Study: 25650964

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric bypass
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laparoscopic duodenal switch
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between gastric bypass and duodenal switch
Number of subjects: 60
Study: 24338119

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 49
Study: 20817859

Group type: EXPERIMENTAL
Intervention: SDAP (10% spray-dried animal plasma)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: auSDAP (10% autoclaved spray-dried animal plasma)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (fish meal basal diet)
Number of subjects: 36
Study: 19387397

Group type: EXPERIMENTAL
Intervention: CM (5 g of creatine)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: PEG1.25 (1.25 g of creatine)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: PEG2.50 (2.50 g of creatine)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: All groups (CM, PEG1.25, PEG2.50)
Number of subjects: 58

Group type: COMPARATOR
Intervention: PL (placebo; 3.6 g of microcrystalline cellulose)
Number of subjects: 58
Study: 17451421

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg per day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 14758131

Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2 daily for 5 days and irinotecan 125 mg/m2 on days 6, 13, and 20 (Schedule A)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2 daily for 5 days and irinotecan 350 mg/m2 on day 6 (Schedule B)
Number of subjects: 32
Study: 11474311

Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg daily
Number of subjects: 396

Group type: COMPARATOR
Intervention: ranitidine 150 mg daily
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg daily (H. pylori-positive patients)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg daily (H. pylori-negative patients)
Number of subjects: 396
Study: 9744238

Group type: EXPERIMENTAL
Intervention: New informative letter
Number of subjects: 185

Group type: COMPARATOR
Intervention: Standard hospital appointment information
Number of subjects: 185
Study: 7920000

Group type: EXPERIMENTAL
Intervention: Methimazole treatment for 4 to 20 months (mean 10.6 months)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Methimazole treatment
Number of subjects: 15
Study: 3414572

Group type: EXPERIMENTAL
Intervention: [1‐13C]palmitic acid (9‐13.5 mg/kg body wt)
Number of subjects: 4

Group type: COMPARATOR
Intervention: [16‐13C]palmitic acid (9‐13.5 mg/kg body wt)
Number of subjects: 4
Study: 31269419

Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 28742643

Group type: EXPERIMENTAL
Intervention: 2-hour protocol using sensitive cardiac troponin I (cTnI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 4-hour protocol using sensitive cardiac troponin I (cTnI)
Number of subjects: 64
Study: 25943999

Group type: EXPERIMENTAL
Intervention: SeniorWISE memory training plus yoga (12 hours total, with a 30-minute yoga component before each session)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: SeniorWISE memory training plus yoga (for those who completed at least 9 hours)
Number of subjects: 133
Study: 23561869

Group type: EXPERIMENTAL
Intervention: Experimental group received soft tissue techniques in the cervical and upper thoracic regions, along with electrotherapy and postural advice.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional group received mobilizations of the shoulder, along with electrotherapy and postural advice.
Number of subjects: 22
Study: 21690318

Group type: EXPERIMENTAL
Intervention: Tobacco smoking independent of nicotine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tobacco smoking with nicotine yield (0.05, 0.6, or 0.9 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cigarette self‐administration
Number of subjects: 20
Study: 19841128

Group type: EXPERIMENTAL
Intervention: 5 ppm iNO
Number of subjects: 793

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 793
Study: 16376428

Group type: EXPERIMENTAL
Intervention: Video-based screening using UPDRS3
Number of subjects: 2081

Group type: COMPARATOR
Intervention: In-person examination using UPDRS3
Number of subjects: 2081

Group type: EXPERIMENTAL
Intervention: Liberal diagnostic criteria for parkinsonism
Number of subjects: 2081

Group type: EXPERIMENTAL
Intervention: Conservative diagnostic criteria for parkinsonism
Number of subjects: 2081
Study: 15016032

Group type: EXPERIMENTAL
Intervention: 0.5% oxybenzone dentifrice
Number of subjects: 66

Group type: COMPARATOR
Intervention: placebo dentifrice
Number of subjects: 66